Blogs written by our own experts or selected members of the drug discovery community.
In this blog, Dr Phil Auckland details how MDC has established a reproducible CRISPR-Cas9 pipeline and generated new tools to better inform nanotherapeutic design
Nanotherapeutics often fail because of Endosomal entrapment. In this blog by Dr Phil Auckland, we explore how MDC are using real-time imaging to reveal why.
Accelerating analgesic development through human-specific in vitro systems
Preclinical to clinical, building a translational link between in vitro and in vivo models of neuroinflammation for drug discovery.
With availability limited and lab facilities not evenly spread across the UK, it is important to make well-informed decisions on the kind of lab space you need early on, because these choices can have consequences further down the line.
See how we can help support you with your next drug discovery project.
Speak to us
